Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance.

Tambon M, Ponté C, Jouanjus E, Fouilhé N, Micallef J, Lapeyre-Mestre M, French Addictovigilance Network (FAN)

Open source

DOI
10.3389/fpsyt.2021.639780
Published
2021
Container
Frontiers in psychiatry
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fpsyt.2021.639780,
  title = {Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance.},
  author = {Tambon M and Ponté C and Jouanjus E and Fouilhé N and Micallef J and Lapeyre-Mestre M and French Addictovigilance Network (FAN)},
  year = {2021},
  journal = {Frontiers in psychiatry},
  doi = {10.3389/fpsyt.2021.639780},
  url = {https://doi.org/10.3389/fpsyt.2021.639780}
}

RIS

TY  - JOUR
TI  - Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance.
AU  - Tambon M
AU  - Ponté C
AU  - Jouanjus E
AU  - Fouilhé N
AU  - Micallef J
AU  - Lapeyre-Mestre M
AU  - French Addictovigilance Network (FAN)
PY  - 2021
JO  - Frontiers in psychiatry
DO  - 10.3389/fpsyt.2021.639780
UR  - https://doi.org/10.3389/fpsyt.2021.639780
ER  - 

APA

M, T., C, P., E, J., N, F., J, M., M, L., & (FAN), F. A. N. (2021). Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance.. Frontiers in psychiatry. https://doi.org/10.3389/fpsyt.2021.639780

Source records